Skip to content

CMF Client CTT Pharmaceutical Holdings (CTTH) Announces Completion of Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer with CanniMed Therapeutics Inc. (CMED)

By Sichenzia Ross Ference LLP | February 17, 2017

SASKATOON, Saskatchewan & STONEY CREEK, Ontario–(BUSINESS WIRE)–Today, CanniMed Therapeutics Inc. (TSX: CMED) and CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) have entered into a definitive contractual relationship for the licensing of CTT’s Orally Dissolvable Thin Film (ODF) Wafer technology. This industry-first collaboration includes the licensing of six patents related to cannabinoid and opioid delivery for pain management,…

Read More
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.